Xuanfei Baidu decoction alleviates intestinal inflammation and modulates microbiota distribution by suppressing IMD/NF-κB and JNK signaling pathways
Frontiers in Microbiology · 10.06.2026 · 17
DOI: 10.3389/fmicb.2026.1853715 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 10.06.2026. Verfasst von Yidong Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Xuanfei Baidu decoction (XFBD), one of China’s recommended prescriptions for COVID-19, has demonstrated clinical efficacy in mitigating gastrointestinal inflammation associated with SARS-CoV-2 infection, yet its exact therapeutic mechanism remains incompletely understood, necessitating further in vivo investigation. In this study, we utilized a fruit fly ( Drosophila melanogaster ) model of intestinal inflammation to assess the therapeutic potential and underlying mechanisms of XFBD in ameliorating intestinal inflammation.
Methods
We induced intestinal inflammation in D. melanogaster by dextran sulfate sodium (DSS) administration. We examined XFBD’s protective effects on D. melanogaster ’s intestine and explored changes in the IMD and JNK-JAK/STAT signaling pathways. Furthermore, we analyzed the intestinal microbiota through 16S rRNA gene sequencing.
Results
XFBD effectively mitigated DSS-induced intestinal inflammation, leading to a significant extension of the flies’ lifespan. It enhanced the integrity of intestinal barrier while reducing reactive oxygen species (ROS) levels in intestine. Additionally, XFBD restored the disrupted intestinal microbiota by regulating immune homeostasis, notably inhibiting the IMD, Toll, and JNKJAK/STAT pathways. Furthermore, the reintroduction of symbiotic microbiota partially alleviated the DSS-induced dysregulation.
Conclusion
In conclusion, our study underscores the therapeutic potential of XFBD for intestinal inflammation, providing valuable insights into its key mechanisms and highlighting the pivotal role of symbiotic microbiota in anti-inflammatory responses and immune pathway regulation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.
- Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
- National Clinical Research Center for Chinese Medicine, Tianjin, China.
- State Key Laboratory for the Creation of Modern Traditional Chinese Medicine, Evidence-Based Medicine Center, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Zitieren
APA
Xu, Y., Li, X., Miao, Y., Liu, X., Zang, X., Meng, Q., Li, Y., Yang, F., Yuchi, Z., & Wang, Y. (2026). Xuanfei Baidu decoction alleviates intestinal inflammation and modulates microbiota distribution by suppressing IMD/NF-κB and JNK signaling pathways. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1853715
Vancouver
Xu Y, Li X, Miao Y, Liu X, Zang X, Meng Q, et al. Xuanfei Baidu decoction alleviates intestinal inflammation and modulates microbiota distribution by suppressing IMD/NF-κB and JNK signaling pathways. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1853715
BibTeX
@article{Xu2026,
author = {Xu, Yidong and Li, Xinyi and Miao, Yaodong and Liu, Xiaoxi and Zang, Xiya and Meng, Qinghao and Li, Ying and Yang, Fengwen and Yuchi, Zhiguang and Wang, Yiwen},
title = {Xuanfei Baidu decoction alleviates intestinal inflammation and modulates microbiota distribution by suppressing IMD/NF-κB and JNK signaling pathways},
journal = {Frontiers in Microbiology},
year = {2026},
volume = {17},
doi = {10.3389/fmicb.2026.1853715}
}
EUVIMED